Small bowel cyclooxygenase 2 (COX-2) expression in patients with IgA nephropathy

Kidney International

Volumn 67, Issue 6, 2005, Pages 2187-2195

  Honkanen, Teemu ^b   Mustonen, Jukka ^b   Kainulainen, Heikki ^b   Myllymäki, Juhani ^b   Collin, Pekka ^b   Hurme, Mikko ^b   Rantala, Immo ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

Cyclooxygenase 2; Fibroblasts; IgA nephropathy; Inflammatory cells; Small bowel mucosa

Indexed keywords

CD15 ANTIGEN; CD3 ANTIGEN; CD45RO ANTIGEN; CD68 ANTIGEN; CYCLOOXYGENASE 2; IMMUNOGLOBULIN A; CD45 ANTIGEN; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM BIOPSY; DYSPEPSIA; FEMALE; GASTROSCOPY; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE; BLOOD; DUODENUM; ENZYMOLOGY; IMMUNOLOGY; MIDDLE AGED;

ADULT; ANTIGENS, CD15; ANTIGENS, CD45; CYCLOOXYGENASE 2; DUODENUM; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 23044464906     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00324.x     Document Type: Article

References (61)

1. COPPO R: The pathogenetic potential of environmental antigens in IgA nephropathy. Am J Kidney Dis 12:420-424, 1988
2. NAGY J, SCOTT H, BRANDTZAEG P: Antibodies to dietary antigens in IgA nephropathy. Clin Nephrol 29:275-279, 1988
3. BENE MC, FAURE GC: Mesangial IgA in IgA nephropathy arises from the mucosa. Am J Kidney Dis 12:406-409, 1988
4. RANTALA I, COLLIN P, HOLM K, et al: Small bowel T cells, HLA class II antigen DR, and GroEL stress protein in IgA nephropathy. Kidney Int 55:2274-2280, 1999
5. ROSTOKER G, DELCHIER JC, CHAUMETTE MT: Increased intestinal intra-epithelial T lymphocytes in primary glomerulonephritis: A role of oral tolerance breakdown in the pathophysiology of human primary glomerulonephritides? Nephrol Dial Transplant 16:513-517, 2001
6. LAI KN, LEUNG JC, LI PK, Lui SF: Cytokine production by peripheral blood mononuclear cells in IgA nephropathy. Clin Exp Immunol 85:240-245, 1991
7. YANO N, ENDOH M, NOMOTO Y, et al: Phenotypic characterization of cytokine expression in patients with IgA nephropathy. J Clin Immunol 17:396-403, 1997
8. MURO K, YAMAGATA K, KOBAYASHI M, et al: Usage of T cell receptor variable segments of the beta-chain in IgA nephropathy. Nephron 92:56-63, 2002
9. HARPER SJ, PRINGLE JH, WICKS AC, et al: Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int 45:836-844, 1994
10. INIGUEZ MA, PUNZON C, FRESNO M: Induction of cyclooxygenase-2 on activated T lymphocytes: Regulation of T cell activation by cyclooxygenase-2 inhibitors. J Immunol 163:111-119, 1999
11. PABLOS JL, SANTIAGO B, CARREIRA PE, et al: Cyclooxygenase-1 and -2 are expressed by human T cells. Clin Exp Immunol 115:86-90, 1999
12. MCCARTHY CJ, CROFFORD LJ, GREENSON J, SCHEIMAN JM: Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. Am J Gastroenterol 94:1218-1223, 1999
13. SCHMASSMANN A, PESKAR BM, STETTLER C, et al: Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastrointestinal ulcer models in rats. Br J Pharmacol 123:795-804, 1998
14. SINGER, II, KAWKA DW, SCHLOEMANN S, et al: Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115:297-306, 1998
15. MUSTONEN J, PASTERNACK A, HELIN H, NIKKILA M: Clinicopathologic correlations in a series of 143 patients with IgA glomerulonephritis. Am J Nephrol 5:150-157, 1985
16. HAAPASALO H, COLLAN Y, ATKIN NB, et al: Prognosis of ovarian carcinomas: Prediction by histoquantitative methods. Histopathology 15:167-178, 1989
17. NEWBERRY RD, STENSON WF, LORENZ RG: Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat Med 5:900-906, 1999
18. PITHA J: The fine structure of clear fibroblast-like cells in the lamina propria of the small intestine. J Ultrastruct Res 22:231-239, 1968
19. GULDNER FH, WOLFF JR, KEYSERLINGK DG: Fibroblasts as a part of the contractile system in duodenal villi of rat. Z Zellforsch Mikrosk Anat 135:349-360, 1972
20. TOYODA H, INA K, KITAMURA H, et al: Organization of the lamina propria mucosae of rat intestinal mucosa, with special reference to the subepithelial connective tissue. Acta Anat 158:172-184, 1997
21. SMITH RS, SMITH TJ, BLIEDEN TM, PHIPPS RP: Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 151:317-322, 1997
22. HALTTUNEN T, MARTTINEN A, RANTALA I, et al: Fibroblasts and transforming growth factor beta induce organization and differentiation of T84 human epithelial cells. Gastroenterology 111:1252-1262, 1996
23. POWELL DW, MIFFLIN RC, VALENTICH JD, et al: Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 277:C1-C9, 1999
24. MIFFLIN RC, SAADA JI, DI MARI JF, et al: Regulation of COX-2 expression in human intestinal myofibroblasts: Mechanisms of IL-1-mediated induction. Am J Physiol Cell Physiol 282:C824-C834, 2002
25. 2 expression in human colonic fibroblasts. Am J Physiol 275:C988-C994, 1998
26. 2-dependent production of interleukin-11 in rheumatoid synovial fibroblasts. Arthritis Rheum 41:2004-2013, 1998
27. NOGUCHI K, SHITASHIGE M, YANAI M, et al: Prostaglandin production via induction of cyclooxygenase-2 by human gingival fibroblasts stimulated with lipopolysaccharides. Inflammation 20:555-568, 1996
28. HINTERLEITNER TA, SAADA JI, BERSCHNEIDER HM, et al: IL-1 stimulates intestinal myofibroblast COX gene expression and augments activation of Cl secretion in T84 cells. Am J Physiol 271:C1262-C1268, 1996
29. XIA Y, PAUZA ME, FENG L, et al: RelB regulation of chemokine expression modulates local inflammation. Am J Pathol 151:375-387, 1997
30. OIDO-MORI M, REZZONICO R, WANG PL, et al: Porphyromonas gingivalis gingipain-R enhances interleukin-8 but decreases gamma interferon-inducible protein 10 production by human gingival fibroblasts in response to T-cell contact. Infect Immun 69:4493-4501, 2001
31. YUCEL-LINDBERG T, BRUNIUS G, WONDIMU B, et al: Enhanced cyclooxygenase-2 mRNA expression in human gingival fibroblasts induced by cell contact with human lymphocytes. Eur J Oral Sci 109:187-192, 2001
32. SEMPOWSKI GD, CHESS PR, PHIPPS RP: CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts. J Immunol 158:4670-4677, 1997
33. WANG HS, CAO HJ, WINN VD, et al: Leukoregulin induction of prostaglandin-endoperoxide H synthase-2 in human orbital fibroblasts. An in vitro model for connective tissue inflammation. J Biol Chem 271:22718-22728, 1996
34. YOSHIOKA K, TAKEMURA T, AYA N, et al: Monocyte infiltration and cross-linked fibrin deposition in IgA nephritis and Henoch-Schoenlein purpura nephritis. Clin Nephrol 32:107-112, 1989
35. ARIMA S, NAKAYAMA M, NAITO M, et al: Significance of mononuclear phagocytes in IgA nephropathy. Kidney Int 39:684-692, 1991
36. ARIAS-NEGRETE S, KELLER K, CHADEE K: Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem Biophys Res Commun 208:582-589, 1995
37. ADAMS DO, HAMILTON TA: Molecular transductional mechanisms by which IFN gamma and other signals regulate macrophage development, Immunol Rev 97:5-27, 1987
38. YOUNGMAN KR, SIMON PL, WEST GA, et al: Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 104:749-758, 1993
39. CASINI-RAGGI V, KAM L, CHONG YJ, et al: Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 154:2434-2440, 1995
40. DINARELLO CA: Biologic basis for interleukin-1 in disease. Blood 87:2095-2147, 1996
41. YUCEL-LINDBERG T, NILSSON S, MODEER T: Signal transduction pathways involved in the synergistic stimulation of prostaglandin production by interleukin-lbeta and tumor necrosis factor alpha in human gingival fibroblasts. J Dent Res 78:61-68, 1999
42. MORITA I, SCHINDLER M, REGIER MK, et al: Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 270:10902-10908, 1995
43. KAINULAINEN H, RANTALA I, COLLIN P, et al: Blisters in the small intestinal mucosa of coeliac patients contain T cells positive for cyclooxygenase 2. Gut 50:84-89, 2002
44. INIGUEZ MA, MARTINEZ-MARTINEZ S, PUNZON C, et al: An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J Biol Chem 275:23627-23635, 2000
45. DE GREGORIO R, INIGUEZ MA, FRESNO M, ALEMANY S: Cot kinase induces cyclooxygenase-2 expression in T cells through activation of the nuclear factor of activated T cells. J Biol Chem 276:27003-27009, 2001
46. WANG J, ANDERS RA, WU Q, et al: Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J Clin Invest 113:826-835, 2004
47. ZEITZ M, ULLRICH R, SCHNEIDER T, et al: Cell differentiation and proliferation in the gastrointestinal tract with respect to the local immune system. Ann N Y Acad Sci 733:75-86, 1994
48. SATO M, HAIZUKA H, ASAKURA H: Relationship between serum IgA levels and CD4 subsets in IgA nephropathy. Nephron 68:20-24, 1994
49. KANTELE A, ARVILOMMI H, JOKINEN I: Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi. J Infect Dis 153:1126-1131, 1986
50. DE FIJTER JW, EIJGENRAAM JW, BRAAM CA, et al: Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 50:952-961, 1996
51. ALLEY CD: Synthesis of IgA by mammalian bone marrow. Adv Exp Med Biol 83:1175-1183, 1987
52. BARRATT J, BAILEY EM, BUCK KS, et al: Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy. Am J Kidney Dis 33:1049-1057, 1999
53. WESTBERG NG, BAKLIEN K, SCHMEKEL B, et al: Quantitation of immunoglobulin-producing cells in small intestinal mucosa of patients with IgA nephropathy. Clin Immunol Immunopathol 26:442-445, 1983
54. HENE RJ, SCHUURMAN HJ, KATER L: Immunoglobulin A subclass-containing plasma cells in the jejunum in primary IgA nephropathy and in Henoch-Schonlein purpura. Nephron 48:4-7, 1988
55. VAN DEN WALL BAKE AW, DAHA MR, HAAIJMAN JJ, et al: Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy. Kidney Int 35:1400-1404, 1989
56. HARPER SJ, ALLEN AC, PRINGLE JH, FEEHALLY J: Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J Clin Pathol 49:38-42, 1996
57. BENNER R, MEIMA F, VAN DER MEULEN GM: Antibody formation in mouse bone marrow. II. Evidence for a memory-dependent phenomenon. Cell Immunol 13:95-106, 1974
58. EMANCIPATOR SN, CHINTALACHARUVU SR, BAGHERI N, et al: Animal models of IgA nephropathy: Formulating therapeutic strategies. Nephrology 3:45-50, 1997
59. ROODNAT JI, DE FIJTER JW, VAN KOOTEN C, et al: Decreased IgA1 response after primary oral immunization with live typhoid vaccine in primary IgA nephropathy. Nephrol Dial Transplant 14:353-359, 1999
60. TOMANA M, NOVAK J, JULIAN BA, et al: Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104:73-81, 1999
61. CHINTALACHARUVU SR, NAGY NU, SIGMUND N, et al: T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation. Clin Exp Immunol 126:326-333, 2001